Potential offtaker

Ipsen SA

www.ipsen.com

N/A
N/A
Which other companies from France are actively involved in decarbonization initiatives?
  • Colas SA
  • Tarkett
  • FM Logistic
  • Fnac Darty
  • Vestiaire Collective
  • Lacoste
  • Ipsen SA is a French biotech company that specializes in the development and production of innovative pharmaceuticals for the treatment of cancer, rare diseases, and other medical conditions. The company was founded in 1929 and has since grown to become a global leader in the biotech industry, with operations in over 30 countries worldwide.

    As a biotech company, Ipsen is acutely aware of the impact that its operations have on the environment. In recent years, the company has taken significant steps to reduce its carbon footprint and promote sustainability across its operations. One of the key ways in which Ipsen is working towards decarbonisation is through the use of renewable energy.

    In 2019, Ipsen signed a corporate power purchase agreement (PPA) with Total Eren, a leading renewable energy company. Under the terms of the agreement, Ipsen will purchase 100% of the electricity produced by a 36 MW solar power plant in Spain for a period of 20 years. This will enable Ipsen to reduce its carbon emissions by an estimated 17,000 tonnes per year, which is equivalent to the emissions from 8,500 cars.

    The corporate PPA is just one of the many ways in which Ipsen is working towards a more sustainable future. The company has also implemented a range of energy efficiency measures across its operations, including the installation of energy-efficient lighting and HVAC systems, the use of renewable energy sources such as solar and wind power, and the implementation of energy management systems to monitor and optimize energy consumption.

    In addition to its efforts to reduce its own carbon footprint, Ipsen is also committed to promoting sustainability across its supply chain. The company works closely with its suppliers to ensure that they adhere to strict environmental and social standards, and has implemented a range of initiatives to promote sustainable sourcing practices.

    One of the key initiatives that Ipsen has implemented is its Corporate Energy Program, which aims to promote energy efficiency and renewable energy across its supply chain. The program provides training and support to suppliers to help them reduce their energy consumption and transition to renewable energy sources.

    Through its Corporate Energy Program, Ipsen has also developed a range of tools and resources to help suppliers measure and report on their energy consumption and carbon emissions. This includes a carbon footprint calculator, which enables suppliers to calculate their carbon emissions and identify areas for improvement.

    Overall, Ipsen's commitment to sustainability and decarbonisation is a key part of its corporate strategy. The company recognizes that the biotech industry has a significant impact on the environment, and is working hard to reduce its carbon footprint and promote sustainability across its operations and supply chain. Through initiatives such as its corporate PPA, energy efficiency measures, and sustainable sourcing practices, Ipsen is leading the way in the biotech sector and demonstrating that it is possible to achieve both commercial success and environmental sustainability.

    ✓ Science Based Targets member
    ✓ Declared Net Zero commitment
    Decarbonization Roadmap for Research and experimental development on biotechnology: Key Insights and Solutions

    Which companies in the industry of Research and experimental development on biotechnology have made significant pledges or efforts to address global warming?
  • Merck KGaA
  • Grifols
  • Bharat Serums and Vaccines
  • Amgen Inc.
  • Gilead Sciences
  • UCB